Industries > Pharma > Global Drug-Device Combination Market 2017-2027

Global Drug-Device Combination Market 2017-2027

Drug Eluting Stents, Photosensitizers, Orthopaedic Products, Infusion Pumps, Wound Care Products, Transmucosal Products, Transdermal Patches, Hospital & Clinics, Ambulatory Surgical Centres, Emergency Service Centres, Home Care Settings

PUBLISHED: 30 August 2017
PAGES: 151
PRODUCT CODE: PHA0230

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE

The global drug-device combination market was valued at $137bn in 2016 and is projected to grow at a CAGR of 6.2% in the first half of the forecast period. In 2016, the market is dominated by the Transmucosal submarket which held 21% share of the drug-device combination market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 151 page report you will receive 124 charts – all unavailable elsewhere.

The 151-page report provides clear detailed insight into the global drug-device combination market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

Global Drug-Device Combination Market forecasts from 2017-2027

• Revenue forecast for the drug-device combination market by End-Users:
– Hospitals & clinics
– Emergency service centers
– Ambulatory surgical centers
– Home care settings

Each submarket is further divided by region: North America, Europe, Asia-Pacific and Rest of the World

• Revenue forecast for the drug-device combination market by Products:
– Drug eluting stents
– Photosensitizers
– Orthopaedic products
– Infusion pumps
– Wound care products
– Transmucosal products
– Transdermal patches
– Others

Each submarket is further divided by region: North America, Europe, Asia-Pacific and Rest of the World

• This report provides individual revenue forecasts from 2017-2027 for these regional and national markets:
North America: The U.S and Rest of North America
Europe: France, Germany, Italy, U.K, Spain, Russia and Rest of Europe
Asia-Pacific: China, India, Japan, and Rest of Asia-Pacific countries
– Rest of the world (RoW): Latin America, and Middle East and African countries

Global Drug-Device Combination Market 2017-2027

Each regional market is further divided by end-users and products

• This report discusses the leading companies in the global drug-device combination market:
– Medtronic
– Boston Scientific Corporation
– Stryker Corporation
– Ethicon Inc
– C.R. Bard Inc.
– Medline Industries Inc.
– Mylan Inc.
– Terumo Corporation
– Pinnacle Biologics Inc.
– W. L. Gore & Associates, Inc.

• This report discusses the drivers, restraints as well as porter’s five forces analysis of the global drug-device combination market

Visiongain’s study is intended for anyone requiring commercial analyses for the global drug-device combination market. You find data, trends and predictions.

Buy our report today Global Drug-Device Combination Market 2017-2027: Drug Eluting Stents, Photosensitizers, Orthopaedic Products, Infusion Pumps, Wound Care Products, Transmucosal Products, Transdermal Patches, Hospital & Clinics, Ambulatory Surgical Centres, Emergency Service Centres, Home Care Settings.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Drug-Device Combination Market 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Global Drug-Device Combination Market 2017-2027


Latest Pharma news

“The worldwide industry for silicone additives is likely to experience important development”, says Visiongain

It is anticipated that the benefits of silicone additives such as elevated drop, marine strength, and leveling & humidity regulate will boost their use in cosmetics, coatings, and paint applications.

16 October 2019

READ

“Global nephrology and urology devices market is anticipated to surpass USD 39 Bn by 2030”, says Visiongain

Nephrology is a field of medicine that is concerned with studying kidney function, treating kidney issues, and therapy for renal substitute.

16 October 2019

READ

“The global Nasal Drug Delivery Technology market is anticipated to surpass USD 80 Billion by 2030”, says Visiongain

Asia Pacific region is anticipated to experience the highest growth in terms of CAGR over the forecast period owing to the availability of effective treatment methods, high unmet clinical needs, rising disposable income levels, and increasing awareness about these products.

16 October 2019

READ

“The global Myeloproliferative Disorders Drugs market is anticipated to surpass USD 11 Bn by 2030”, says Visiongain

The emergence of a new therapy for myeloproliferative disorders and the accessibility of new drugs is anticipated to drive the market drugs for myeloproliferative disorders.

16 October 2019

READ

Categories

Category